Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 711

1.

A large-scale drug screen identifies selective inhibitors of class I HDACs as a potential therapeutic option for SHH medulloblastoma.

Pak E, MacKenzie EL, Zhao X, Pazyra-Murphy MF, Park PMC, Wu L, Shaw DL, Addleson EC, Cayer SS, Lopez BG, Agar NYR, Rubin LL, Qi J, Merk DJ, Segal RA.

Neuro Oncol. 2019 May 16. pii: noz089. doi: 10.1093/neuonc/noz089. [Epub ahead of print]

PMID:
31111916
2.

Prospective observational study of early respiratory management in preterm neonates less than 35 weeks of gestation.

Moya FR, Mazela J, Shore PM, Simonson SG, Segal R, Simmons PD, Gregory TJ, Guardia CG, Varga JR, Finer NN; Preterm Neonate Early Respiratory Management Prospective Observational Study investigators.

BMC Pediatr. 2019 May 11;19(1):147. doi: 10.1186/s12887-019-1518-3.

3.

Home hospice for older people with advanced dementia: a pilot project.

Sternberg SA, Sabar R, Katz G, Segal R, Fux-Zach L, Grupman V, Roth G, Cohen N, Radomyslaski Z, Bentur N.

Isr J Health Policy Res. 2019 May 6;8(1):42. doi: 10.1186/s13584-019-0304-x.

4.

A New Era For Tattoos, with New Potential Complications.

Maarouf M, Saberian C, Segal RJ, Shi VY.

J Clin Aesthet Dermatol. 2019 Feb;12(2):37-38. Epub 2019 Feb 1.

5.

NCI Clinical Trials Planning Meeting for prevention and treatment of chemotherapy-induced peripheral neuropathy.

Dorsey SG, Kleckner IR, Barton D, Mustian K, O'Mara A, St Germain D, Cavaletti G, Danhauer SC, Hershman D, Hohmann AG, Hoke A, Hopkins JO, Kelly KP, Loprinzi CL, McLeod HL, Mohile S, Paice J, Rowland JH, Salvemini D, Segal RA, Lavoie Smith E, McCaskill Stevens W, Janelsins MC.

J Natl Cancer Inst. 2019 Jan 31. doi: 10.1093/jnci/djz011. [Epub ahead of print]

PMID:
30715378
6.

Does integration of Magee equations into routine clinical practice affect whether oncologists order the Oncotype DX test? A prospective randomized trial.

Robertson SJ, Ibrahim MFK, Stober C, Hilton J, Kos Z, Mazzarello S, Ramsay T, Fergusson D, Vandermeer L, Mallick R, Arnaout A, Dent SF, Segal R, Sehdev S, Gertler S, Hutton B, Clemons M.

J Eval Clin Pract. 2019 Apr;25(2):196-204. doi: 10.1111/jep.13094. Epub 2019 Jan 23.

PMID:
30672056
7.

A phase II randomized controlled trial of three exercise delivery methods in men with prostate cancer on androgen deprivation therapy.

Alibhai SMH, Santa Mina D, Ritvo P, Tomlinson G, Sabiston C, Krahn M, Durbano S, Matthew A, Warde P, O'Neill M, Timilshina N, Segal R, Culos-Reed N.

BMC Cancer. 2019 Jan 3;19(1):2. doi: 10.1186/s12885-018-5189-5.

8.

Extramammary Paget's disease: a review of the literature.

Simonds RM, Segal RJ, Sharma A.

Int J Dermatol. 2018 Dec 19. doi: 10.1111/ijd.14328. [Epub ahead of print] Review.

PMID:
30569580
9.

Sonic Hedgehog Signaling is Blue: Insights from the Patched Mutant Mice.

Merk DJ, Segal RA.

Trends Neurosci. 2018 Dec;41(12):870-872. doi: 10.1016/j.tins.2018.08.013. Review.

PMID:
30471664
10.

Differences between Men and Women Regarding Early Maladaptive Schemas in an Australian Adult Alcohol Dependent Clinical Sample.

Janson DL, Harms CA, Hollett RC, Segal RD.

Subst Use Misuse. 2019;54(2):177-184. doi: 10.1080/10826084.2018.1480038. Epub 2018 Nov 13.

PMID:
30422042
11.

Cutaneous Adverse Effects of Diabetes Mellitus Medications and Medical Devices: A Review.

Jedlowski PM, Te CH, Segal RJ, Fazel MT.

Am J Clin Dermatol. 2019 Feb;20(1):97-114. doi: 10.1007/s40257-018-0400-7. Review.

PMID:
30361953
12.

Long-term efficacy of combination vismodegib and photodynamic therapy for multiple basal cell carcinomas.

Zullo SW, Zeitouni NC, Segal RJ.

Photodiagnosis Photodyn Ther. 2018 Dec;24:164-165. doi: 10.1016/j.pdpdt.2018.09.016. Epub 2018 Oct 3. No abstract available.

PMID:
30291952
13.

A rare cause of unilateral facial rash.

Krase IZ, Wickenheiser M, Chao J, Kurtzman D, Segal R, Culpepper K, Shi V.

Clin Exp Dermatol. 2019 Jun;44(4):425-427. doi: 10.1111/ced.13749. Epub 2018 Sep 19. No abstract available.

PMID:
30229995
14.

A randomised controlled trial comparing fibreoptic-guided tracheal intubation through two supraglottic devices: Ambu® AuraGain™ laryngeal mask and LMA® Fastrach™.

Preece G, Ng I, Lee K, Mezzavia P, Krieser R, Williams DL, Stewart O, Segal R.

Anaesth Intensive Care. 2018 Sep;46(5):474-479.

PMID:
30189821
15.

Association Between Recombinant Human Bone Morphogenetic Proteins and Postoperative Opioid Use in Lumbar Fusion Procedure Patients: A Propensity Score-Matched Analysis.

Murimi IB, Ghambaryan A, Decker R, Lu X, Segal R, Loyo-Berrios N, Marinac-Dabic D, Hartzema AG.

World Neurosurg. 2018 Dec;120:e42-e52. doi: 10.1016/j.wneu.2018.07.125. Epub 2018 Aug 28.

PMID:
30170146
16.

Incomplete methylation of a germ cell tumor (Seminoma) in a Prader-Willi male.

Eldar-Geva T, Gross-Tsur V, Hirsch HJ, Altarescu G, Segal R, Zeligson S, Golomb E, Epsztejn-Litman S, Eiges R.

Mol Genet Genomic Med. 2018 Sep;6(5):811-818. doi: 10.1002/mgg3.448. Epub 2018 Jul 12.

17.

The use of Transnasal Humidified Rapid-Insufflation Ventilatory Exchange (THRIVE) for pre-oxygenation in neurosurgical patients: a randomised controlled trial.

Ng I, Krieser R, Mezzavia P, Lee K, Tseng C, Douglas N, Segal R.

Anaesth Intensive Care. 2018 Jul;46(4):360-367.

PMID:
29966108
18.

A transatlantic cooperation for enriched neuroscience training.

Witter MP, Karagogeos D, Van Bockstaele EJ, Segal RA.

Eur J Neurosci. 2018 Jul;48(2):1717-1719. doi: 10.1111/ejn.14056. Epub 2018 Jul 4. No abstract available.

PMID:
29938860
19.

The tolerogenic peptide hCDR1 immunomodulates cytokine and regulatory molecule gene expression in blood mononuclear cells of primary Sjogren's syndrome patients.

Sthoeger Z, Sharabi A, Asher I, Zinger H, Segal R, Shearer G, Elkayam O, Mozes E.

Clin Immunol. 2018 Jul;192:85-91. doi: 10.1016/j.clim.2018.05.001. Epub 2018 May 4.

PMID:
29730433
20.

Trends in Readmission Rates, Hospital Charges, and Mortality for Patients With Chronic Obstructive Pulmonary Disease (COPD) in Florida From 2009 to 2014.

Jiang X, Xiao H, Segal R, Mobley WC, Park H.

Clin Ther. 2018 Apr;40(4):613-626.e1. doi: 10.1016/j.clinthera.2018.03.006. Epub 2018 Mar 31.

PMID:
29609879
21.

Risk of sudden sensorineural hearing loss in adults using phosphodiesterase type 5 inhibitors: Population-based cohort study.

Liu W, Antonelli PJ, Dahm P, Gerhard T, Delaney JAC, Segal R, Crystal S, Winterstein AG.

Pharmacoepidemiol Drug Saf. 2018 Jun;27(6):587-595. doi: 10.1002/pds.4405. Epub 2018 Mar 7.

PMID:
29512263
22.

Compression stockings as an effective treatment for erythema nodosum: Case series.

Golisch KB, Gottesman SP, Segal RJ.

Int J Womens Dermatol. 2017 Sep 29;3(4):231-233. doi: 10.1016/j.ijwd.2017.09.001. eCollection 2017 Dec.

23.

A randomised controlled trial comparing high-flow nasal oxygen with standard management for conscious sedation during bronchoscopy.

Douglas N, Ng I, Nazeem F, Lee K, Mezzavia P, Krieser R, Steinfort D, Irving L, Segal R.

Anaesthesia. 2018 Feb;73(2):169-176. doi: 10.1111/anae.14156. Epub 2017 Nov 24.

24.

Combination vismodegib and photodynamic therapy for multiple basal cell carcinomas.

Rizzo JM, Segal RJ, Zeitouni NC.

Photodiagnosis Photodyn Ther. 2018 Mar;21:58-62. doi: 10.1016/j.pdpdt.2017.10.028. Epub 2017 Nov 2.

PMID:
29102653
25.

What explains the different rates of human papillomavirus vaccination among adolescent males and females in the United States?

Choi Y, Eworuke E, Segal R.

Papillomavirus Res. 2016 Dec;2:46-51. doi: 10.1016/j.pvr.2016.02.001. Epub 2016 Mar 4.

26.

Identifying and characterizing preventable adverse drug events for prioritizing pharmacist intervention in hospitals.

Jeon N, Staley B, Johns T, Lipori GP, Brumback B, Segal R, Winterstein AG.

Am J Health Syst Pharm. 2017 Nov 1;74(21):1774-1783. doi: 10.2146/ajhp160387. Erratum in: Am J Health Syst Pharm. 2017 Dec 1;74(23 ):1928. Am J Health Syst Pharm. 2017 Dec 15;74(24):2030. Am J Health Syst Pharm. 2017 Dec 15;74(24):2030.

PMID:
29070499
27.

Stimulants Do Not Increase the Risk of Seizure-Related Hospitalizations in Children with Epilepsy.

Liu X, Carney PR, Bussing R, Segal R, Cottler LB, Winterstein AG.

J Child Adolesc Psychopharmacol. 2018 Mar;28(2):111-116. doi: 10.1089/cap.2017.0110. Epub 2017 Oct 13.

28.

Paclitaxel Reduces Axonal Bclw to Initiate IP3R1-Dependent Axon Degeneration.

Pease-Raissi SE, Pazyra-Murphy MF, Li Y, Wachter F, Fukuda Y, Fenstermacher SJ, Barclay LA, Bird GH, Walensky LD, Segal RA.

Neuron. 2017 Oct 11;96(2):373-386.e6. doi: 10.1016/j.neuron.2017.09.034.

29.

Evaluation of multiplex real-time PCR for identifying dermatophytes in clinical samples-A multicentre study.

Sherman S, Goshen M, Treigerman O, Ben-Zion K, Carp MJ, Maisler N, Ehrenreich IB, Kimchi A, Lifshitz S, Smollan G, Davidovici B, David M, Hodak E, Segal R.

Mycoses. 2018 Feb;61(2):119-126. doi: 10.1111/myc.12713. Epub 2017 Nov 15.

PMID:
29024067
30.

Risk prediction model for in-hospital mortality in women with ST-elevation myocardial infarction: A machine learning approach.

Mansoor H, Elgendy IY, Segal R, Bavry AA, Bian J.

Heart Lung. 2017 Nov - Dec;46(6):405-411. doi: 10.1016/j.hrtlng.2017.09.003. Epub 2017 Oct 6.

PMID:
28992993
31.

Complete Remission in Locally Advanced Breast Cancer: What Comprehensive Multi-Modality Treatment Has to Offer in Sub-Saharan Africa.

Bhattacharya G, Msadabwe-Chikuni SC, Segal R, Inamdar O, Mwaba CK.

Cureus. 2017 Jul 6;9(7):e1432. doi: 10.7759/cureus.1432.

32.

A Transposon Screen Identifies Loss of Primary Cilia as a Mechanism of Resistance to SMO Inhibitors.

Zhao X, Pak E, Ornell KJ, Pazyra-Murphy MF, MacKenzie EL, Chadwick EJ, Ponomaryov T, Kelleher JF, Segal RA.

Cancer Discov. 2017 Dec;7(12):1436-1449. doi: 10.1158/2159-8290.CD-17-0281. Epub 2017 Sep 18.

33.

A Mechanistic Understanding of Axon Degeneration in Chemotherapy-Induced Peripheral Neuropathy.

Fukuda Y, Li Y, Segal RA.

Front Neurosci. 2017 Aug 31;11:481. doi: 10.3389/fnins.2017.00481. eCollection 2017. Review.

34.

Presurgical weight loss affects tumour traits and circulating biomarkers in men with prostate cancer.

Demark-Wahnefried W, Rais-Bahrami S, Desmond RA, Gordetsky JB, Hunter GR, Yang ES, Azrad M, Frugé AD, Tsuruta Y, Norian LA, Segal R, Grizzle WE.

Br J Cancer. 2017 Oct 24;117(9):1303-1313. doi: 10.1038/bjc.2017.303. Epub 2017 Sep 7.

35.

Radiation Mitigating Properties of Intranasally Administered KL4 Surfactant in a Murine Model of Radiation-Induced Lung Damage.

Christofidou-Solomidou M, Pietrofesa RA, Arguiri E, Koumenis C, Segal R.

Radiat Res. 2017 Nov;188(5):491-504. doi: 10.1667/RR14686.1. Epub 2017 Sep 6.

36.

Exercise for people with cancer: a systematic review.

Segal R, Zwaal C, Green E, Tomasone JR, Loblaw A, Petrella T; Exercise for People with Cancer Guideline Development Group.

Curr Oncol. 2017 Aug;24(4):e290-e315. doi: 10.3747/co.24.3619. Epub 2017 Aug 31. Review.

37.

Mycetoma (Madura Foot) in Israel: Recent Cases and a Systematic Review of the Literature.

Bitan O, Wiener-Well Y, Segal R, Schwartz E.

Am J Trop Med Hyg. 2017 Jun;96(6):1355-1361. doi: 10.4269/ajtmh.16-0710. Review.

38.

Trends in Antiepileptic Drug Use in Children and Adolescents With Epilepsy.

Liu X, Carney PR, Bussing R, Segal R, Cottler LB, Winterstein AG.

Pediatr Neurol. 2017 Sep;74:32-40. doi: 10.1016/j.pediatrneurol.2017.05.016. Epub 2017 May 29.

PMID:
28676250
39.

Duration of Reproductive Years and the Risk of Cardiovascular and Cerebrovascular Events in Older Women: Insights from the National Health and Nutrition Examination Survey.

Mansoor H, Elgendy IY, Segal R, Hartzema A.

J Womens Health (Larchmt). 2017 Oct;26(10):1047-1052. doi: 10.1089/jwh.2016.6013. Epub 2017 May 19.

PMID:
28525295
40.
41.

A Unique Clinicopathological Manifestation of Fungal Infection: A Case Series of Deep Dermatophytosis in Immunosuppressed Patients.

Kershenovich R, Sherman S, Reiter O, Huss SR, Didkovsky E, Mimouni D, Hodak E, Segal R.

Am J Clin Dermatol. 2017 Oct;18(5):697-704. doi: 10.1007/s40257-017-0276-y.

PMID:
28389891
42.

Exercise for people with cancer: a clinical practice guideline.

Segal R, Zwaal C, Green E, Tomasone JR, Loblaw A, Petrella T; Exercise for People with Cancer Guideline Development Group.

Curr Oncol. 2017 Feb;24(1):40-46. doi: 10.3747/co.24.3376. Epub 2017 Feb 27.

43.

An Empirical vs Risk-Based Approach Algorithm to Intracavernosal Injection Therapy: A Prospective Study.

Bernie HL, Segal R, Le B, Burnett A, Bivalacqua TJ.

Sex Med. 2017 Mar;5(1):e31-e36. doi: 10.1016/j.esxm.2016.08.001.

44.

Erratum to: Feasibility outcomes of a presurgical randomized controlled trial exploring the impact of caloric restriction and increased physical activity versus a wait-list control on tumor characteristics and circulating biomarkers in men electing prostatectomy for prostate cancer.

Demark-Wahnefried W, Nix JW, Hunter GR, Rais-Bahrami S, Desmond RA, Chacko B, Morrow CD, Azrad M, Frugé AD, Tsuruta Y, Ptacek T, Tully SA, Segal R, Grizzle WE.

BMC Cancer. 2017 Jan 23;17(1):71. doi: 10.1186/s12885-016-3025-3. No abstract available.

45.

A brain-penetrant RAF dimer antagonist for the noncanonical BRAF oncoprotein of pediatric low-grade astrocytomas.

Sun Y, Alberta JA, Pilarz C, Calligaris D, Chadwick EJ, Ramkissoon SH, Ramkissoon LA, Garcia VM, Mazzola E, Goumnerova L, Kane M, Yao Z, Kieran MW, Ligon KL, Hahn WC, Garraway LA, Rosen N, Gray NS, Agar NY, Buhrlage SJ, Segal RA, Stiles CD.

Neuro Oncol. 2017 Jun 1;19(6):774-785. doi: 10.1093/neuonc/now261.

46.

Combining adverse pregnancy and perinatal outcomes for women exposed to antiepileptic drugs during pregnancy, using a latent trait model.

Wen X, Hartzema A, Delaney JA, Brumback B, Liu X, Egerman R, Roth J, Segal R, Meador KJ.

BMC Pregnancy Childbirth. 2017 Jan 6;17(1):10. doi: 10.1186/s12884-016-1190-7.

47.

Improving Comprehensive Medication Review Acceptance by Using a Standardized Recruitment Script: A Randomized Control Trial.

Miguel A, Hall A, Liu W, Garrett J, Ballew A, Yang TH, Segal R.

J Manag Care Spec Pharm. 2017 Jan;23(1):13-21. doi: 10.18553/jmcp.2017.23.1.13.

48.

Hedgehog Signal Transduction: Key Players, Oncogenic Drivers, and Cancer Therapy.

Pak E, Segal RA.

Dev Cell. 2016 Aug 22;38(4):333-44. doi: 10.1016/j.devcel.2016.07.026. Review.

49.

Tyrosine receptor kinase B is a drug target in astrocytomas.

Ni J, Xie S, Ramkissoon SH, Luu V, Sun Y, Bandopadhayay P, Beroukhim R, Roberts TM, Stiles CD, Segal RA, Ligon KL, Hahn WC, Zhao JJ.

Neuro Oncol. 2017 Jan;19(1):22-30. doi: 10.1093/neuonc/now139. Epub 2016 Jul 10.

50.

Impact of resistance and aerobic exercise on sarcopenia and dynapenia in breast cancer patients receiving adjuvant chemotherapy: a multicenter randomized controlled trial.

Adams SC, Segal RJ, McKenzie DC, Vallerand JR, Morielli AR, Mackey JR, Gelmon K, Friedenreich CM, Reid RD, Courneya KS.

Breast Cancer Res Treat. 2016 Aug;158(3):497-507. doi: 10.1007/s10549-016-3900-2. Epub 2016 Jul 9.

PMID:
27394134

Supplemental Content

Support Center